Veraxa Biotech Holding AG (VRXAW) Non-Current Debt (2024 - 2025)
Veraxa Biotech Holding AG (VRXAW) posted quarterly Non-Current Debt of $3.6 million for Q4 2025, up 51.32% year-over-year from $2.4 million in Q4 2024, and up 51.32% quarter-over-quarter from $2.4 million in Q4 2024.
Veraxa Biotech Holding AG (VRXAW) Non-Current Debt (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXAW) has reported Non-Current Debt for 2 consecutive years, with $3.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Non-Current Debt rose 51.32% year-over-year to $3.6 million; the TTM figure through Dec 2025 stood at $3.6 million (up 51.32% YoY), while the FY2025 annual figure was $3.6 million, up 51.32% from the prior year.
- Non-Current Debt climbed to $3.6 million in Q4 2025 per VRXAW's latest filing, from $2.4 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $3.6 million in Q4 2025 and bottomed at $2.4 million in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.63 Mn |
| Dec 31, 2024 | 2.40 Mn |